Litcius/Paper detail

Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial

Neil Gupta, Linda Manirambona, Fabienne Shumbusho, Jules Kabihizi, Anthère Murangwa, Janvier Serumondo, Jean Damascène Makuza, Sabin Nsanzimana, Claude Mambo Muvunyi, Constance Mukabatsinda, Emmanuel Musabeyezu, Grégory Camus, Philip Grant, Fredrick Kateera

2022˜The œLancet. Gastroenterology & hepatology18 citationsDOI

Topics & Concepts

MedicineHepatitis C virusSofosbuvirAntiviral treatmentVirusChronic hepatitisIntensive care medicineVirologyInternal medicineRibavirinHepatitis C virus researchHIV/AIDS drug development and treatmentHepatitis Viruses Studies and Epidemiology
Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial | Litcius